Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
44.75 GBX | -0.78% | -4.28% | -61.59% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 01 | Avacta picks Christina Coughlin to replace long-serving CEO | AN |
Sales 2023 | 23.25M 29.01M | Sales 2024 * | 24.5M 30.57M | Capitalization | 160M 200M |
---|---|---|---|---|---|
Net income 2023 | -24M -29.95M | Net income 2024 * | -27M -33.69M | EV / Sales 2023 | 14 x |
Net cash position 2023 * | 16.2M 20.22M | Net cash position 2024 * | 22.4M 27.95M | EV / Sales 2024 * | 5.63 x |
P/E ratio 2023 |
-12.7
x | P/E ratio 2024 * |
-5.82
x | Employees | 120 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.66% |
Latest transcript on Avacta Group Plc
1 day | -0.78% | ||
1 week | -4.28% | ||
Current month | -2.19% | ||
1 month | -16.36% | ||
3 months | -55.69% | ||
6 months | -69.35% | ||
Current year | -61.59% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 16-01-03 |
Matt Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 13-09-15 |
Michael Vinegrad
IRO | Public Communications Contact | - | 14-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Nicholls
BRD | Director/Board Member | 67 | 13-08-01 |
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 16-01-03 |
Paul Fry
BRD | Director/Board Member | 58 | 20-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 44.75 | -0.78% | 265 368 |
24-05-07 | 45.1 | -0.88% | 3,413,113 |
24-05-03 | 45.5 | -2.15% | 4,092,357 |
24-05-02 | 46.5 | -0.53% | 2,722,374 |
24-05-01 | 46.75 | +2.19% | 2,495,493 |
Delayed Quote London S.E., May 08, 2024 at 05:17 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-61.59% | 201M | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.97% | 23.47B | |
-13.89% | 21.9B | |
-5.89% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- AVCT Stock